X4 Pharmaceuticals, Inc. (XFOR)
4.04
0.00 (0.00%)
USD |
NASDAQ |
Aug 31, 16:00
4.05
+0.01
(+0.25%)
After-Hours: 20:00
X4 Pharmaceuticals Net Income (TTM) : -90.14M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -90.14M |
| March 31, 2026 | -99.72M |
| December 31, 2025 | -79.20M |
| September 30, 2025 | -95.10M |
| June 30, 2025 | -101.98M |
| March 31, 2025 | 14.60M |
| December 31, 2024 | -37.45M |
| September 30, 2024 | -16.76M |
| June 30, 2024 | 17.63M |
| March 31, 2024 | -128.91M |
| December 31, 2023 | -101.17M |
| September 30, 2023 | -111.14M |
| June 30, 2023 | -130.42M |
| March 31, 2023 | -95.92M |
| December 31, 2022 | -93.87M |
| September 30, 2022 | -94.97M |
| June 30, 2022 | -93.56M |
| March 31, 2022 | -91.98M |
| December 31, 2021 | -88.70M |
| September 30, 2021 | -76.89M |
| Date | Value |
|---|---|
| June 30, 2021 | -74.16M |
| March 31, 2021 | -69.67M |
| December 31, 2020 | -62.13M |
| September 30, 2020 | -54.57M |
| June 30, 2020 | -54.83M |
| March 31, 2020 | -53.07M |
| December 31, 2019 | -52.81M |
| September 30, 2019 | -53.25M |
| June 30, 2019 | -44.14M |
| March 31, 2019 | -36.79M |
| December 31, 2018 | -33.28M |
| September 30, 2018 | -33.19M |
| June 30, 2018 | -36.19M |
| March 31, 2018 | -35.86M |
| December 31, 2017 | -33.88M |
| September 30, 2017 | -28.01M |
| June 30, 2017 | -25.40M |
| March 31, 2017 | -24.86M |
| December 31, 2016 | -22.98M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Sarepta Therapeutics, Inc. | -266.10M |
| Arrowhead Pharmaceuticals, Inc. | -272.12M |
| Oncolytics Biotech, Inc. | -30.07M |
| Sangamo Therapeutics, Inc. | -123.33M |
| Anixa Biosciences, Inc. | -10.12M |